Perspective Therapeutics Statistics
Total Valuation
CATX has a market cap or net worth of $313.92 million. The enterprise value is $81.00 million.
| Market Cap | 313.92M |
| Enterprise Value | 81.00M |
Important Dates
The next estimated earnings date is Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CATX has 114.15 million shares outstanding. The number of shares has increased by 29.45% in one year.
| Current Share Class | 114.15M |
| Shares Outstanding | 114.15M |
| Shares Change (YoY) | +29.45% |
| Shares Change (QoQ) | +16.45% |
| Owned by Insiders (%) | 0.57% |
| Owned by Institutions (%) | 55.22% |
| Float | 70.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 767.52 |
| Forward PS | 1,882.22 |
| PB Ratio | 0.97 |
| P/TBV Ratio | 1.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 198.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.61, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.61 |
| Quick Ratio | 6.49 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -410.60 |
Financial Efficiency
Return on equity (ROE) is -39.57% and return on invested capital (ROIC) is -26.22%.
| Return on Equity (ROE) | -39.57% |
| Return on Assets (ROA) | -22.28% |
| Return on Invested Capital (ROIC) | -26.22% |
| Return on Capital Employed (ROCE) | -35.23% |
| Weighted Average Cost of Capital (WACC) | 14.33% |
| Revenue Per Employee | $2,464 |
| Profits Per Employee | -$701,410 |
| Employee Count | 166 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -793,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.91% in the last 52 weeks. The beta is 1.85, so CATX's price volatility has been higher than the market average.
| Beta (5Y) | 1.85 |
| 52-Week Price Change | -17.91% |
| 50-Day Moving Average | 2.98 |
| 200-Day Moving Average | 3.61 |
| Relative Strength Index (RSI) | 45.84 |
| Average Volume (20 Days) | 2,288,221 |
Short Selling Information
The latest short interest is 22.81 million, so 19.98% of the outstanding shares have been sold short.
| Short Interest | 22.81M |
| Short Previous Month | 23.04M |
| Short % of Shares Out | 19.98% |
| Short % of Float | 32.20% |
| Short Ratio (days to cover) | 19.63 |
Income Statement
In the last 12 months, CATX had revenue of $409,000 and -$116.43 million in losses. Loss per share was -$1.25.
| Revenue | 409,000 |
| Gross Profit | -95.77M |
| Operating Income | -125.23M |
| Pretax Income | -117.42M |
| Net Income | -116.43M |
| EBITDA | -121.19M |
| EBIT | -125.23M |
| Loss Per Share | -$1.25 |
Balance Sheet
The company has $236.88 million in cash and $3.96 million in debt, with a net cash position of $232.91 million or $2.04 per share.
| Cash & Cash Equivalents | 236.88M |
| Total Debt | 3.96M |
| Net Cash | 232.91M |
| Net Cash Per Share | $2.04 |
| Equity (Book Value) | 323.86M |
| Book Value Per Share | 2.84 |
| Working Capital | 204.98M |
Cash Flow
In the last 12 months, operating cash flow was -$93.07 million and capital expenditures -$28.12 million, giving a free cash flow of -$121.19 million.
| Operating Cash Flow | -93.07M |
| Capital Expenditures | -28.12M |
| Depreciation & Amortization | 4.05M |
| Net Borrowing | -54,000 |
| Free Cash Flow | -121.19M |
| FCF Per Share | -$1.06 |
Margins
| Gross Margin | n/a |
| Operating Margin | -30,619.07% |
| Pretax Margin | -28,710.02% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CATX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -29.45% |
| Shareholder Yield | -29.45% |
| Earnings Yield | -37.09% |
| FCF Yield | -38.60% |
Analyst Forecast
The average price target for CATX is $12.29, which is 346.91% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.29 |
| Price Target Difference | 346.91% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | -26.42% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 17, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 17, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
CATX has an Altman Z-Score of 1.15 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.15 |
| Piotroski F-Score | 2 |